Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-011 · synthetic case ANEM-FX-24

Hemolysis markers without a reticulocyte response

A DAT-positive case.

Synthetic · no real patientAuthored by Biod · reviewed by Dr. AmaralAnemia engine v1.0.0

Purpose: A DAT-positive case.

Inputs the engine received

CBC and reticulocytes

Hemoglobin
9.1 g/dL
Hematocrit
28 %
MCV
100 fL
Reticulocytes
1 %

Patient

Age
39 years
Sex
Female

Hemolysis, kidney and thyroid

LDH
480 U/L
Haptoglobin
8 mg/dL
Direct antiglobulin test positive
Yes

What the engine reports

Detected clinical pattern

Anemia — Pattern Compatible With Hemolysis

Moderate anemia, normocytic. A pattern for physician review; the cause still has to be found.

  • Severity: Moderate anemia (Hb 9.1 g/dL)
  • Morphology: Normocytic (MCV 80–100)
  • Marrow response: Marrow response inadequate (RPI 0.31)

Calculations

Corrected reticulocyte count
0.62%

Reticulocyte % × (hematocrit ÷ 45).

Reticulocyte production index
0.31

Corrected count ÷ maturation factor. 2 or more is an appropriate marrow response.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Direct antiglobulin test, blood film and a search for the cause (autoimmune, mechanical, hereditary, drug, infection).

Missing information

  • Ferritin (and transferrin saturation).
Evidence and rule trace · 6 rules

AN-CALC-01Derived values

Inputs: RPI 0.31

Derived values calculated.

AN-01Anemia present, with severity

Inputs: hemoglobin 9.1 g/dL (<12)

Anemia, moderate.

AN-02Morphology by MCV

Inputs: MCV 100 fL

Normocytic anemia.

AN-03Marrow response

Inputs: retic 1% · hematocrit 28% · RPI 0.31

Inadequate marrow response.

AN-14Hemolysis pattern

Inputs: LDH 480 U/L · haptoglobin 8 mg/dL · direct antiglobulin test positive

Pattern compatible with hemolysis.

AN-MISS-01Information needed

Inputs: Ferritin

First-line studies are incomplete.

Evidence

  • EV-WHO-HB-2011 · World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011.
  • EV-TEFFERI-2003 · Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc. 2003;78(10):1274-1280.
  • EV-MENTZER-1973 · Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808):882.
  • EV-JAGER-2020 · Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev. 2020;41:100648.

Physician adjudication required. Clinical decision support for physician review. This output classifies anemia by morphology and marrow response and lists patterns and safety considerations. It does not diagnose a cause, rank causes by probability, or select treatment or transfusion. Physician adjudication is required.

Change the values

The same engine, starting from this case. Change any value and watch the pattern and the rule trace react.

Morphology

  1. ✓ Microcytic

    MCV <80 fL

  2. ● Normocytic

    MCV 80–100 fL

  3. ○ Macrocytic

    MCV >100 fL

Marrow response (reticulocyte production index)

  1. ● Inadequate · RPI <2

    Hypoproliferative: deficiency, inflammation, kidney, marrow

  2. ○ Appropriate · RPI ≥2

    Blood loss, hemolysis or recovery

CBC and reticulocytes
  • <7
  • 7–8
  • 8–11
  • 11–13
  • ≥13
Patient
Sex
Iron, vitamins and inflammation
Hemolysis, kidney and thyroid

250 U/L is assumed when empty.

Blood film and other context

Live result · computed in your browser

Detected clinical pattern

Anemia — Pattern Compatible With Hemolysis

Moderate anemia, normocytic. A pattern for physician review; the cause still has to be found.

  • Severity: Moderate anemia (Hb 9.1 g/dL)
  • Morphology: Normocytic (MCV 80–100)
  • Marrow response: Marrow response inadequate (RPI 0.31)

Calculations

Corrected reticulocyte count
0.62%

Reticulocyte % × (hematocrit ÷ 45).

Reticulocyte production index
0.31

Corrected count ÷ maturation factor. 2 or more is an appropriate marrow response.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Direct antiglobulin test, blood film and a search for the cause (autoimmune, mechanical, hereditary, drug, infection).

Missing information

  • Ferritin (and transferrin saturation).
Evidence and rule trace · 6 rules

AN-CALC-01Derived values

Inputs: RPI 0.31

Derived values calculated.

AN-01Anemia present, with severity

Inputs: hemoglobin 9.1 g/dL (<12)

Anemia, moderate.

AN-02Morphology by MCV

Inputs: MCV 100 fL

Normocytic anemia.

AN-03Marrow response

Inputs: retic 1% · hematocrit 28% · RPI 0.31

Inadequate marrow response.

AN-14Hemolysis pattern

Inputs: LDH 480 U/L · haptoglobin 8 mg/dL · direct antiglobulin test positive

Pattern compatible with hemolysis.

AN-MISS-01Information needed

Inputs: Ferritin

First-line studies are incomplete.

Evidence

  • EV-WHO-HB-2011 · World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011.
  • EV-TEFFERI-2003 · Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc. 2003;78(10):1274-1280.
  • EV-MENTZER-1973 · Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808):882.
  • EV-JAGER-2020 · Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev. 2020;41:100648.

Physician adjudication required. Clinical decision support for physician review. This output classifies anemia by morphology and marrow response and lists patterns and safety considerations. It does not diagnose a cause, rank causes by probability, or select treatment or transfusion. Physician adjudication is required.

More anemia cases

All anemia cases

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod